JPH10175854A - 津液改善用皮膚外用剤 - Google Patents
津液改善用皮膚外用剤Info
- Publication number
- JPH10175854A JPH10175854A JP26052897A JP26052897A JPH10175854A JP H10175854 A JPH10175854 A JP H10175854A JP 26052897 A JP26052897 A JP 26052897A JP 26052897 A JP26052897 A JP 26052897A JP H10175854 A JPH10175854 A JP H10175854A
- Authority
- JP
- Japan
- Prior art keywords
- general formula
- skin
- represented
- group
- embedded image
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 40
- 239000003814 drug Substances 0.000 title claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract description 15
- 230000001737 promoting effect Effects 0.000 claims abstract description 46
- 230000009471 action Effects 0.000 claims abstract description 40
- 150000001875 compounds Chemical class 0.000 claims abstract description 33
- 230000000694 effects Effects 0.000 claims abstract description 27
- 230000028327 secretion Effects 0.000 claims abstract description 22
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims abstract description 10
- DNXHEGUUPJUMQT-UHFFFAOYSA-N (+)-estrone Natural products OC1=CC=C2C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 DNXHEGUUPJUMQT-UHFFFAOYSA-N 0.000 claims abstract description 7
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 claims abstract description 7
- DNXHEGUUPJUMQT-CBZIJGRNSA-N Estrone Chemical compound OC1=CC=C2[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 DNXHEGUUPJUMQT-CBZIJGRNSA-N 0.000 claims abstract description 7
- 229960005309 estradiol Drugs 0.000 claims abstract description 7
- 229930182833 estradiol Natural products 0.000 claims abstract description 7
- 229960003399 estrone Drugs 0.000 claims abstract description 7
- 125000003545 alkoxy group Chemical group 0.000 claims abstract description 4
- 150000003839 salts Chemical class 0.000 claims description 24
- 201000004624 Dermatitis Diseases 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- 206010012438 Dermatitis atopic Diseases 0.000 claims description 13
- 201000008937 atopic dermatitis Diseases 0.000 claims description 13
- 230000003779 hair growth Effects 0.000 claims description 13
- 230000001079 digestive effect Effects 0.000 claims description 10
- 239000002537 cosmetic Substances 0.000 claims description 9
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 9
- 239000004480 active ingredient Substances 0.000 claims description 8
- 230000001882 diuretic effect Effects 0.000 claims description 8
- 208000007163 Dermatomycoses Diseases 0.000 claims description 7
- 208000012641 Pigmentation disease Diseases 0.000 claims description 7
- 201000004681 Psoriasis Diseases 0.000 claims description 7
- 206010039796 Seborrhoeic keratosis Diseases 0.000 claims description 7
- 208000000260 Warts Diseases 0.000 claims description 7
- 201000003929 dermatomycosis Diseases 0.000 claims description 7
- 201000010153 skin papilloma Diseases 0.000 claims description 7
- 230000019612 pigmentation Effects 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 5
- 125000004429 atom Chemical group 0.000 claims description 4
- 230000037380 skin damage Effects 0.000 claims description 4
- 230000035900 sweating Effects 0.000 claims description 4
- PROQIPRRNZUXQM-UHFFFAOYSA-N (16alpha,17betaOH)-Estra-1,3,5(10)-triene-3,16,17-triol Natural products OC1=CC=C2C3CCC(C)(C(C(O)C4)O)C4C3CCC2=C1 PROQIPRRNZUXQM-UHFFFAOYSA-N 0.000 claims description 3
- WCTPJCYSFNTVKJ-UHFFFAOYSA-N 4-hydroxy-n-(4-hydroxyphenyl)benzamide Chemical compound C1=CC(O)=CC=C1NC(=O)C1=CC=C(O)C=C1 WCTPJCYSFNTVKJ-UHFFFAOYSA-N 0.000 claims description 3
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 claims description 3
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 claims description 3
- 125000004423 acyloxy group Chemical group 0.000 claims description 3
- 229940061641 androsterone Drugs 0.000 claims description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims description 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 3
- 230000002500 effect on skin Effects 0.000 claims description 3
- PROQIPRRNZUXQM-ZXXIGWHRSA-N estriol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H]([C@H](O)C4)O)[C@@H]4[C@@H]3CCC2=C1 PROQIPRRNZUXQM-ZXXIGWHRSA-N 0.000 claims description 3
- 229960001348 estriol Drugs 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- MYRPHDZSPRUVHB-UHFFFAOYSA-N 4-(4-phenylhexa-2,4-dien-3-yl)phenol Chemical compound C=1C=CC=CC=1C(=CC)C(=CC)C1=CC=C(O)C=C1 MYRPHDZSPRUVHB-UHFFFAOYSA-N 0.000 claims description 2
- RMHMYTLAUXIOPR-UHFFFAOYSA-N 4-hydroxy-n-phenylbenzamide Chemical compound C1=CC(O)=CC=C1C(=O)NC1=CC=CC=C1 RMHMYTLAUXIOPR-UHFFFAOYSA-N 0.000 claims description 2
- NFDFQCUYFHCNBW-UHFFFAOYSA-N dienestrol Chemical compound C=1C=C(O)C=CC=1C(=CC)C(=CC)C1=CC=C(O)C=C1 NFDFQCUYFHCNBW-UHFFFAOYSA-N 0.000 claims description 2
- 206010048222 Xerosis Diseases 0.000 claims 1
- 210000000056 organ Anatomy 0.000 abstract description 3
- 230000004936 stimulating effect Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 41
- 208000010668 atopic eczema Diseases 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 8
- -1 stilbesterol Chemical compound 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 206010048218 Xeroderma Diseases 0.000 description 6
- 206010021198 ichthyosis Diseases 0.000 description 6
- 229940079593 drug Drugs 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 230000002496 gastric effect Effects 0.000 description 5
- 230000001225 therapeutic effect Effects 0.000 description 5
- 238000001816 cooling Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000027939 micturition Effects 0.000 description 4
- 239000008194 pharmaceutical composition Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 210000004243 sweat Anatomy 0.000 description 4
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 208000017520 skin disease Diseases 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 210000002700 urine Anatomy 0.000 description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 230000010933 acylation Effects 0.000 description 2
- 238000005917 acylation reaction Methods 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000012156 elution solvent Substances 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000003636 fecal output Effects 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000003248 secreting effect Effects 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- DZPCYXCBXGQBRN-UHFFFAOYSA-N 2,5-Dimethyl-2,4-hexadiene Chemical compound CC(C)=CC=C(C)C DZPCYXCBXGQBRN-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- KDPQTPZDVJHMET-UHFFFAOYSA-N 3-acetoxy-1,3,5(10)-estratrien-17-one Natural products C1CC2(C)C(=O)CCC2C2CCC3=CC(OC(=O)C)=CC=C3C21 KDPQTPZDVJHMET-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 240000004731 Acer pseudoplatanus Species 0.000 description 1
- 235000002754 Acer pseudoplatanus Nutrition 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000282817 Bovidae Species 0.000 description 1
- ZWMQVDDAFYCYCQ-PLFPLCLSSA-N C(CCCCCCCCCCCCCC)(=O)OC1(CC[C@@H]2[C@]1(C)CC[C@@H]1C3=C(CC[C@@H]21)C=C(O)C=C3)O Chemical compound C(CCCCCCCCCCCCCC)(=O)OC1(CC[C@@H]2[C@]1(C)CC[C@@H]1C3=C(CC[C@@H]21)C=C(O)C=C3)O ZWMQVDDAFYCYCQ-PLFPLCLSSA-N 0.000 description 1
- 238000011735 C3H mouse Methods 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 235000006485 Platanus occidentalis Nutrition 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- KDPQTPZDVJHMET-XSYGEPLQSA-N [(8r,9s,13s,14s)-13-methyl-17-oxo-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-yl] acetate Chemical compound C1C[C@]2(C)C(=O)CC[C@H]2[C@@H]2CCC3=CC(OC(=O)C)=CC=C3[C@H]21 KDPQTPZDVJHMET-XSYGEPLQSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000001350 alkyl halides Chemical class 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 239000003788 bath preparation Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000004211 gastric acid Anatomy 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- TYTBNGNVQHWXDL-UHFFFAOYSA-N hexa-2,4-dien-3-ylbenzene Chemical compound CC=CC(=CC)C1=CC=CC=C1 TYTBNGNVQHWXDL-UHFFFAOYSA-N 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- PBBGSZCBWVPOOL-UHFFFAOYSA-N hexestrol Chemical compound C=1C=C(O)C=CC=1C(CC)C(CC)C1=CC=C(O)C=C1 PBBGSZCBWVPOOL-UHFFFAOYSA-N 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP26052897A JPH10175854A (ja) | 1996-10-18 | 1997-09-25 | 津液改善用皮膚外用剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8-276659 | 1996-10-18 | ||
| JP27665996 | 1996-10-18 | ||
| JP26052897A JPH10175854A (ja) | 1996-10-18 | 1997-09-25 | 津液改善用皮膚外用剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH10175854A true JPH10175854A (ja) | 1998-06-30 |
| JPH10175854A5 JPH10175854A5 (enExample) | 2004-11-25 |
Family
ID=26544645
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP26052897A Pending JPH10175854A (ja) | 1996-10-18 | 1997-09-25 | 津液改善用皮膚外用剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH10175854A (enExample) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001085154A3 (en) * | 2000-05-12 | 2002-08-29 | Univ Oregon Health Sciences | Method of treating immune pathologies with low dose estrogen |
| FR2840530A1 (fr) * | 2002-06-11 | 2003-12-12 | Oreal | Composition cosmetique comprenant un agent inducteur de l'expression de la dopachrome tautomerase (trp-2) pour lutter contre la canitie |
| US7462486B2 (en) | 2000-05-12 | 2008-12-09 | Oregon Health & Science University | Methods of selecting T cell receptor V peptides for therapeutic use |
| US7514583B2 (en) | 2002-05-31 | 2009-04-07 | Proteotech, Inc. | Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| US7629375B2 (en) | 2001-07-23 | 2009-12-08 | Johnson & Johnson Consumer Companies, Inc. | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| JP2011162513A (ja) * | 2010-02-12 | 2011-08-25 | Sunny Place:Kk | ザクロ種子抽出エキス、及びその医薬組成物、飲食物、化粧品、並びにその使用方法 |
| US8053197B2 (en) | 2004-07-30 | 2011-11-08 | Oregon Health & Science University | Methods for detecting and treating autoimmune disorders |
| AT510867A5 (de) * | 2009-03-23 | 2012-12-15 | Sami Labs Ltd | Melanogenesehemmung durch 3,5-dimethoxy-4'-hydroxystilbene und kosmetische zusammensetzungen hievon |
| US8754133B2 (en) | 2001-11-02 | 2014-06-17 | Proteotech, Inc. | Compounds, compositions and methods for the treatment of inflammatory diseases |
-
1997
- 1997-09-25 JP JP26052897A patent/JPH10175854A/ja active Pending
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7579006B2 (en) | 2000-05-12 | 2009-08-25 | Oregon Health And Science University | Method of treating immune pathologies with low dose estrogen |
| AU2001259847B2 (en) * | 2000-05-12 | 2006-02-02 | Oregon Health And Science University | Method of treating immune pathologies with low dose estrogen |
| AU2001259847B8 (en) * | 2000-05-12 | 2006-02-23 | Oregon Health And Science University | Method of treating immune pathologies with low dose estrogen |
| US7462486B2 (en) | 2000-05-12 | 2008-12-09 | Oregon Health & Science University | Methods of selecting T cell receptor V peptides for therapeutic use |
| WO2001085154A3 (en) * | 2000-05-12 | 2002-08-29 | Univ Oregon Health Sciences | Method of treating immune pathologies with low dose estrogen |
| US7629375B2 (en) | 2001-07-23 | 2009-12-08 | Johnson & Johnson Consumer Companies, Inc. | Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| US8754133B2 (en) | 2001-11-02 | 2014-06-17 | Proteotech, Inc. | Compounds, compositions and methods for the treatment of inflammatory diseases |
| US7514583B2 (en) | 2002-05-31 | 2009-04-07 | Proteotech, Inc. | Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes, and parkinson's disease |
| US8163957B2 (en) | 2002-05-31 | 2012-04-24 | Proteotech, Inc. | Compounds, compositions and methods for the treatment of amyloid diseases and synucleinopathies such as alzheimer's disease, type 2 diabetes and parkinson's disease |
| WO2003103568A3 (fr) * | 2002-06-11 | 2004-05-06 | Oreal | Utilisation d'un agent inducteur de l'expression de la dopachrome tautomerase (trp-2) comme agent protecteur des melanocytes du follicule pileux |
| FR2840530A1 (fr) * | 2002-06-11 | 2003-12-12 | Oreal | Composition cosmetique comprenant un agent inducteur de l'expression de la dopachrome tautomerase (trp-2) pour lutter contre la canitie |
| US8053197B2 (en) | 2004-07-30 | 2011-11-08 | Oregon Health & Science University | Methods for detecting and treating autoimmune disorders |
| AT510867A5 (de) * | 2009-03-23 | 2012-12-15 | Sami Labs Ltd | Melanogenesehemmung durch 3,5-dimethoxy-4'-hydroxystilbene und kosmetische zusammensetzungen hievon |
| JP2011162513A (ja) * | 2010-02-12 | 2011-08-25 | Sunny Place:Kk | ザクロ種子抽出エキス、及びその医薬組成物、飲食物、化粧品、並びにその使用方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3631259B2 (ja) | 医薬組成物 | |
| WO1992010178A1 (fr) | Medicament et composition antiprurigineux | |
| JPH10114649A (ja) | 津液改善剤及びそれを含有する経口投与用組成物 | |
| JPH06312918A (ja) | 養毛剤とその製造方法 | |
| JP2010520232A (ja) | 玄参抽出物を含有する外用剤組成物及びその皮膚保湿化粧料としての用途 | |
| HU218921B (hu) | Stroncium (II) valamely szervetlen sója topikális alkalmazása neurogén eredetű bőrelváltozások kezelésére alkalmas gyógyszerkészítmények előállítására | |
| JPH07300412A (ja) | 活性酸素消去剤及びこれを含む組成物 | |
| JPH10175854A (ja) | 津液改善用皮膚外用剤 | |
| KR101503158B1 (ko) | 피부 주름 개선 및 탄력 증진용 화장료 조성물 | |
| JPH10120579A (ja) | 津液改善用皮膚外用剤 | |
| WO2017111069A1 (ja) | 止痒剤 | |
| JPH10175859A (ja) | 津液改善用皮膚外用剤 | |
| JPH10120558A (ja) | 津液改善用皮膚外用剤 | |
| JP2023038290A (ja) | ロイシン誘導体、それを含む組成物及びその用途 | |
| JP4018764B2 (ja) | 津液改善用皮膚外用剤 | |
| JP2018514554A (ja) | 脂肪を低減させるための美容上の方法及び治療用途 | |
| JP4100805B2 (ja) | 化粧料 | |
| JPH10175868A (ja) | 津液改善組成物 | |
| JPH10114665A (ja) | 津液改善剤及びそれを含有する経口投与用組成物 | |
| US20150258158A1 (en) | Compositions and methods for inhibition of triglyceride synthesis via synergistic combination of botanical formulations | |
| JPH10120561A (ja) | 津液改善用皮膚外用剤 | |
| JPH10175852A (ja) | 津液改善剤及びそれを含有する経口投与用組成物 | |
| JP4049406B2 (ja) | 津液改善剤及びそれを含有する経口投与用組成物 | |
| JPH0296581A (ja) | ビオチンエステル及びそれを用いた皮膚外用剤、養毛料 | |
| JPH10114652A (ja) | 津液改善剤及びそれを含有する経口投与用組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20070703 |
|
| A977 | Report on retrieval |
Effective date: 20070705 Free format text: JAPANESE INTERMEDIATE CODE: A971007 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20071030 |